4

PRIMARY DOCUMENT

Company: LIGAND PHARMACEUTICALS INC
Filed: March 13, 2020
Period of Report: March 13, 2020
Accession Number: 0000886163-20-000029

View Document ↗ View on SEC.gov ↗